Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs ASE Technology Holding Co Ltd (ASX) Price & Performance

Amylx Pharmaceuticals IncTrade
ASE Technology Holding Co LtdTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs ASE Technology Holding Co Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.66 (market cap $2.64B), while ASE Technology Holding Co Ltd trades at $39.54 (market cap $85.75B). The key difference: ASE Technology Holding Co Ltd is far larger — about 32.5× Amylx Pharmaceuticals Inc's market cap, and ASE Technology Holding Co Ltd pays a 1.08% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXASX
Market Cap
$2.64B$85.75B
Sector
HealthTechnology
52-Week High
$24.19$45.12
52-Week Low
$7.82$9.63
Enterprise Value
$2.39B$90.15B
Dividend Yield
1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

No Aura AI signal available yet.

ASE Technology Holding Co Ltd

ASE Technology Holding (ASX) trades at $37.59, up 0.53% today, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.29, exceeding expectations, and announced a $10.5 billion capital expenditure increase for AI-driven semiconductor demand (Reuters, 2026-07-30). Financials show revenue growth to $645.39 billion in 2025 and a net income margin of 8.46%, though valuation ratios like P/E of 47.78 appear elevated.

Outlook is positive due to AI capacity expansion and robust institutional interest, with 80% analyst buy ratings. Risks include high valuation sensitivity and execution challenges from increased capital spending. The stock's momentum is supported by earnings growth, but investors should monitor margin sustainability amid competitive pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About ASE Technology Holding Co Ltd

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, packaging services contribute the most revenue. It involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufacture and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Read more on ASX